Hot or Not, Stock Market Edition: 07/07/2026

Happy Tuesday. Here's what the Zen Ratings are prescribing and diagnosing today:

• Hot: Medical device turnaround Smith & Nephew (SNN) is riding a robotics tailwind; Invisalign maker Align Technology (ALGN) is quietly emerging as an AI dentistry play
• Not: Quantum computing pioneer IonQ (IONQ) is running out of steam; building products distributor QXO (QXO) is stuck in reverse

P.S. For more stocks making moves, check out our Zen Ratings Upgrades & Downgrades screener.

A note from our sponsors...

🔥 HOT: Medical device leader Smith & Nephew (SNN) is winning strong surgeon backing for its robotics push. It just launched its next-generation CORI XT Handheld Robotics Platform for knee and shoulder surgery and its LEAF Patient Monitoring System, while completing its acquisition of Integrity Orthopaedics to build out an unrivalled shoulder repair portfolio. The stock perked a mere 5% last Thursday on the latest results, but our data suggests the move could be just ramping up.  

SNN earns an A Zen Rating from WallStreetZen's 115-factor model, placing it among the top 4% of stocks tracked — a group that has delivered an average annual return of nearly 30%. The company earns B grades across Value, Safety, and Financials, a strong triple-B combination that reflects an attractive valuation, defensive resilience, and solid financial strength. Smith & Nephew is transforming robotics innovation and strategic acquisitions into one of the sector's most compelling turnaround stories. 

🥶 NOT:  Building products distributor QXO (QXO) has been rapidly rolling up building products distribution assets, most recently through its acquisition of TopBuild — but the stock fell after merger election results showed most shareholders opted for cash over stock, hardly a vote of confidence, and law firms have since launched shareholder investigations probing the price and process of the deal. Shares have plunged over 40% from their 52-week high, while profit margin has collapsed from over 65% to -6% in the past year.  

The ratings underscore the deterioration. QXO holds an F Zen Rating (Strong Sell) and, despite operating in the B-rated App industry, ranks near dead last at #166 of 175 — a striking underperformer. Looking at the Component Grades, the company earns an F for Safety alongside D grades for Value, Momentum, Sentiment, and AI — five weak grades compounded by a debt load near $4 billion that operating cash flow can't currently service. An ambitious roll-up strategy only works if the balance sheet can carry it, and right now QXO's can't. 

🔥 HOT:  Dental technology leader Align Technology (ALGN) doesn’t just make Invisalign transparent dental aligners. It just announced a major AI-powered digital dentistry platform alongside plans for a new multi-million dollar manufacturing facility in Hyderabad, India. The stock has surged over 50% from its 52-week low, with Q1 earnings showing global growth and DSO channel strength offsetting softer North America demand. Analysts remain firmly bullish: 8 of 10 rate it a Strong Buy or Buy, with some forecasts suggesting the stock could see 30% upside from current levels. 

The fundamentals fully support the rally. ALGN earns an A Zen Rating, placing it among the top 3% of stocks tracked. Looking at the Zen Component Grades, the company receives B grades across Value, Growth, Safety, and Financials — a great combination that pairs an attractive valuation with strong growth potential, defensive resilience, and solid financial strength. Ranked #5 out of 93 companies in the Medical Device industry and expected to grow earnings by more than 32% annually, Align offers something increasingly difficult to find: a genuine AI growth story still trading at a reasonable price. 

🥶 NOT:  Quantum computing pioneer IonQ (IONQ) is losing ground as investors start separating quantum winners from quantum hype. The company develops trapped-ion quantum computers and has been riding the broader AI investing wave — but the stock plummeted over 30% in the past month, and a slew of articles have been raising the alarm bell. Additionally, the CEO, CFO, and multiple directors have all been selling shares throughout May and June 2026. 

The ratings paint a challenging picture. IONQ holds an F-rated Strong Sell — a tier that has averaged an annual loss of nearly 13%. Looking at the Component Grades that shape the overall score, the company earns F grades for Safety and AI alongside D grades for Value and Financials, with a forecast Return on Equity of negative 5%, cash burn expected to exceed $1 billion next year, and a #30 of 31 ranking in Computer Hardware. Bullish analyst price targets and a compelling quantum narrative can't paper over numbers like these — until they improve, IonQ is a story stock without the fundamentals to back it 

What to Do Next?

• 77 Best Stocks NOW! >
• Options Trading with the Zen Ratings >
• 2 New Stocks to Buy from Steve Reitmeister >

Want to get in touch? Email us at news@wallstreetzen.com.